A cataract that has material basis in variation in the region 12q24.2-q24.3.
Comprehensive, easy-to-understand information about this condition
How we create this content →Documentation for cataract 37 is limited due to its rarity and the absence of systematic clinical studies. As this condition affects a small number of individuals, comprehensive research is challenging. Additionally, the genetic basis is still being investigated, which contributes to the gaps in clinical characterization and understanding of the condition.
To navigate your care for cataract 37, consider seeking a specialist in hereditary eye disorders or a geneticist who can provide insights into genetic counseling. While there are currently no identified patient organizations, you can access resources such as the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov for additional support and information. Participating in clinical trials may also provide opportunities for access to novel therapies and contribute to the understanding of this condition.
Currently, there is one active clinical trial related to cataract 37. You can explore this trial further by visiting ClinicalTrials.gov and searching for 'cataract 37' to find details on participation and objectives. While there are no orphan drugs designated for this condition, the ongoing research may lead to new insights and potential treatment options in the future.
Actionable guidance for navigating care for cataract 37
To navigate your care for cataract 37, consider seeking a specialist in hereditary eye disorders or a geneticist who can provide insights into genetic counseling. While there are currently no identified patient organizations, you can access resources such as the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov for additional support and information. Participating in clinical trials may also provide opportunities for access to novel therapies and contribute to the understanding of this condition.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
Documentation for cataract 37 is limited due to its rarity and the absence of systematic clinical studies. As this condition affects a small number of individuals, comprehensive research is challenging. Additionally, the genetic basis is still being investigated, which contributes to the gaps in clinical characterization and understanding of the condition.
To navigate your care for cataract 37, consider seeking a specialist in hereditary eye disorders or a geneticist who can provide insights into genetic counseling. While there are currently no identified patient organizations, you can access resources such as the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov for additional support and information. Participating in clinical trials may also provide opportunities for access to novel therapies and contribute to the understanding of this condition.
Currently, there is one active clinical trial related to cataract 37. You can explore this trial further by visiting ClinicalTrials.gov and searching for 'cataract 37' to find details on participation and objectives. While there are no orphan drugs designated for this condition, the ongoing research may lead to new insights and potential treatment options in the future.
Actionable guidance for navigating care for cataract 37
To navigate your care for cataract 37, consider seeking a specialist in hereditary eye disorders or a geneticist who can provide insights into genetic counseling. While there are currently no identified patient organizations, you can access resources such as the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov for additional support and information. Participating in clinical trials may also provide opportunities for access to novel therapies and contribute to the understanding of this condition.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
Documentation for cataract 37 is limited due to its rarity and the absence of systematic clinical studies. As this condition affects a small number of individuals, comprehensive research is challenging. Additionally, the genetic basis is still being investigated, which contributes to the gaps in clinical characterization and understanding of the condition.
To navigate your care for cataract 37, consider seeking a specialist in hereditary eye disorders or a geneticist who can provide insights into genetic counseling. While there are currently no identified patient organizations, you can access resources such as the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov for additional support and information. Participating in clinical trials may also provide opportunities for access to novel therapies and contribute to the understanding of this condition.
Currently, there is one active clinical trial related to cataract 37. You can explore this trial further by visiting ClinicalTrials.gov and searching for 'cataract 37' to find details on participation and objectives. While there are no orphan drugs designated for this condition, the ongoing research may lead to new insights and potential treatment options in the future.
Actionable guidance for navigating care for cataract 37
To navigate your care for cataract 37, consider seeking a specialist in hereditary eye disorders or a geneticist who can provide insights into genetic counseling. While there are currently no identified patient organizations, you can access resources such as the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov for additional support and information. Participating in clinical trials may also provide opportunities for access to novel therapies and contribute to the understanding of this condition.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
Inheritance patterns describe how genetic conditions are passed from parents to children.
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Jan 7, 2026
Consider asking your healthcare providers these condition-specific questions
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
AI-Generated Content: This summary was generated using AI. Always consult with qualified healthcare providers for medical guidance.
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.